TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Malaysian conglomerate breaks ground on stem cell clinic in Bali
Aside from a clinic, Genting Group also plans to establish a local manufacturing unit to supply stem cells to the clinic and other hospitals across the country, operating under the license and supervision of US-based biotech firm Celularity.
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Future clinic site: The Sanur Special Economic Zone (SEZ) in Bali is seen in this undated aerial photo. The area has been tapped as the future site of a stem cell clinic intended to attract patients from around the world seeking regenerative therapies. (Hotel Indonesia Natour/-)
P
T Astana Bangun Sejahtera, a subsidiary of Malaysian conglomerate Genting Group, broke ground on Wednesday on a stem cell clinic in Bali’s Sanur Special Economic Zone (SEZ).
The clinic, Fontaine Vitale, set to occupy a 0.9-hectare site under a 30-year lease agreement, is designed to serve both local and international patients.
Astana plans to operate the facility in collaboration with two local entities, PT Sentosa Bersama Mitra and PT Bintang Graha Hijau.
For the medical technology, the company plans to leverage Genting’s partnership with United States-based biotechnology firm Celularity, known for developing placenta-derived stem cells and other biomaterial products.
Stem cells are a unique type of cell with the ability to develop into various specialized cell types and self-renew. Because of these properties, researchers have studied the potential of injecting stem cells into patients to treat injuries or cure degenerative diseases, such as Parkinson's disease and osteoarthritis.
Stem cells can be sourced from umbilical cord blood, bone marrow and fat tissue.
Read also: Medical tourism: Turning the tide for Indonesian patients
